ÀÚ·á¹®ÀÇ:02-703-5000/info@oic.co.kr
À¯ÀüÀÚ Áúº´&Ä¡·á
¹é½Å
³¿¬Á¦
IT ¹× »çÀ̹ö º¸¾È
ȯ°æ¹®Á¦
¹Ì¿ë/¼ºÇü
ÀÚµ¿Â÷ À¶ÇÕ/¹Ì·¡»ê¾÷
ÀçÈ°¿ë
Áö¿À¸Åƽ½º/ÅÚ·¹¸Åƽ½º
ÅÂ¾ç¿ ¿¡³ÊÁö
¹ÙÀÌ¿À¸ÞÄ«Æ®·Î´Ð½º
Á¢ÂøÁ¦&Á¡ÂøÁ¦
ÄÚÆÃ
¿þ¾î·¯ºí ÀåÄ¡,±â±â
»ö¼Ò,¾È·á,¿°·á
»ýÈÇÐ
¸ð´ÏÅ͸µ ½Ã½ºÅÛ
¼ö·Â¹ßÀü
±×¸°¿¬·á/¹ÙÀÌ¿À¿¬·á
üÁß°ü¸®/ºñ¸¸Ä¡·á
dz·Â ¿¡³ÊÁö
Àü·Â¹ÝµµÃ¼
ÀÇ¾à °ü·Ã ¹«¿ª,Àü·«
½º¸¶Æ®È¨&½º¸¶Æ®ºôµù
Æó±â¹° ó¸®
³ÃÀå°í
ÈÇÐÇ° ±ÔÁ¦
Ä«¸Þ¶ó
¾ËÃ÷ÇÏÀ̸Ó/Ä¡¸Å/ÆÄŲ½¼
·Îº¿ »ê¾÷
¼¾¼
Ä¡°ú¿ë ±â±â
¾È°ú¿ë ±â±â
°íÁÖÆÄ, ¹«¼± ÁÖÆļö
Flexible display
ÀǾàÇ° Á¦Á¶±â¾÷
ÀÇ·á¿ë/¹ÙÀÌ¿À ÀÎÆ÷¸Åƽ½º
»ýüÀç·á/»ýüÈí¼ö
»ýü¸ð¹æ/»ýŸð¹æ
¹ÙÀÌ¿À¸â½º/¹ÙÀÌ¿À³ª³ë
ÅëÇÕ °Ë»ö
¾ç¼
Àϼ
all of these words
any of these words
Àΰ£ÀÇ °¨¼º¿¡ °¡±î¿î...
¹Ì·¡ ¿¹Ãø¿¡ ÀÇÇÑ ¿¬...
ÀÚµ¿Â÷ ½Ç³»ÀÇ Á¤¼÷¼º...
±Ý¼Ó ³ª³ë ÀÔÀÚ, ¹Ì¸³...
** ÇÒÀÎÀÚ·á Àüü
***************************
Àüü
|
¿µ¹®¸¸
|
ÀϹ®¸¸
Èñ±ÍÁúȯ
(ÁÖÁ¦¿Í °ü·Ã¾øÀ¸¸é "»õ·Î°íħ" ÇØÁÖ¼¼¿ä)
ÀÚ·á¸í
°¡°Ý
¹ßÇàÀÏ
2012-2013 Á¦³×¸¯ ÀǾàÇ°¡¤Àå±â ¼öÀçÇ°(¼±¹ß ÀǾàÇ°) µ¥ÀÌÅÍ ºÏ No.1 ±â¾÷Æí
¡Í 140,000
2012-11
Generic Drugs: World Market Outlook 2011-2021(¼¼°è Á¦³×¸¯ ¾àÇ° ½ÃÀå)
¡Ì 1,549
2012-11
Èñ¼Ò Áúȯ/³Ä¡º´ ÀÇ Áø´Ü¡¤Ä¡·á¿Í Á¦Ç° °³¹ß
¡Í40,000 ÇÒÀΰ¡
¡Í 95,000
2012-10
Profound Research and Investment Prospect of China¡¯s Generic Drug Market, 2012-2016(Áß±¹ÀÇ Á¦³×¸¯ ÀǾàÇ° ÅõÀÚ ¿¹»ó ½ÃÀå)
$ 1,800
2012-08
Èñ¼Ò Áúº´¾àÀÇ ±Û·Î¹ú °³¹ß 2012
¡Í 95,000
2012-07
Top 194 Generic Pharmaceuticals (Global)(Àü¼¼°è ÁÖ¿ä 194 Á¦³×¸¯ ÀǾàÇ°)
¡Ì 950
2012-07
Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making(ÀǾàÇ° ÆÄÀÌÇÁ¶óÀÎ ÀçÆò°¡ - ÇâÈÄ ÀÇ»ç°áÁ¤À» Çü¼ºÇÏ´Â ½ÅÈï ½ÃÀå, »ý¹°Á¦Á¦ ¹× Èñ±ÍÀǾàÇ°)
$ 3,500
2012-06
Generic Defense Strategies(Á¦³×¸¯ µðÆ潺 Àü·«)
$ 3,835
2012-05
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer strong Opportunities for Investment and Licensing Activity(À¯Àü¼º Èñ±ÍÁúȯ Ä¡·á : ³¶Æ÷¼º ¼¶À¯Áõ(CF) ½Å¹°ÁúÀÌ Á¦°øÇÏ´Â °·ÂÇÑ ÅõÀÚ ±âȸ ¹× ¶óÀ̼¾½Ì È°µ¿)
$ 3,500
2012-05
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution(½ÉÇ÷°ü Áúȯ¿ë Á¦³×¸¯ ÀǾàÇ° ½ÃÀå)
$ 3,500
2012-05
Orphan Diseases Therapeutics in CNS to 2017-Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington¡¯s Disease Segment(ÁßÃ߽Űæ°è Èñ±ÍÁúȯ Ä¡·á ½ÃÀå)
$ 3,500
2012-04
Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022(ÀǾàÇ° ¸®´õ ½Ã¸®Áî : ÁÖ¿ä 50 Á¦³×¸¯ ¾àÇ° Á¦Á¶»ç)
¡Ì 1,699
2012-03
Neurometabolic Disorders Market to 2017 - Novel therapies for Rare Diseases Such As Gaucher and Niemann-Pick Poised to Supersede Existing Therapies(½Å°æ´ë»ç Àå¾Ö ½ÃÀå)
$ 3,500
2012-03
Japan Generics Market Analysis(ÀϺ»ÀÇ Á¦³×¸¯ ÀǾàÇ° ½ÃÀåºÐ¼®)
$ 1,000
2012-02
Generic Pharmaceuticals Industry(Á¦³×¸¯ ÀǾàÇ° »ê¾÷)
¡Ì 950
2012-01
1
2
3
4
5
6
7
8
9
±Ý¿¬Ä¡·áÁ¦
Èñ±ÍÁúȯ
Å°³ª¾ÆÁ¦
Á¦³×¸¯ ÀǾàÇ°
¹æ»ç¼º ÀǾàÇ°
ó¹æ¾à
¹ÙÀÌ¿ÀÀǾà
»ý¾à,Çѹæ,¾àÃÊ
ÁÖ»çÁ¦
ÀÇ·á¿ë ¸¶¾à ¹× ´ë¸¶
Åë½Å
ÀüÀÚ
Áß°ø¾÷
Á¦¾à
ÈÇÐ
ÀÇÇÐ
ȯ°æ
½ÄÇ°
¹æÀ§»ê¾÷
±âŸ
.
-¿¬±¸°³¹ß¸®´õ
.
-CosmeticStage
.
-PharmStage
.
-MaterialStage
.
-Â÷Àç Technology
.
.
.
.
ID(email)
Password
ºñ¹Ð¹øÈ£ ºÐ½Ç
ȸ¿ø°¡ÀÔ
ÈÆó
ȯÀ²
(ÇϳªÀºÇà ¼Û±Ýº¸³¾¶§)
¹Ì±¹USD
\ 1,397.60
ÀϺ»JPY
\ 9.0396
À¯·ÎEUR
\ 1,487.19
¿µ±¹GBP
\ 1,737.29
Copyright¨Ï2024 OIC(Overseas Information Center) All Rights Reserved.
04373 ¼¿ï½Ã ¿ë»ê±¸ ÀÌÃÌ·Î 1(GSÇÑ°¿¡Å¬¶óÆ®) 1121È£
E_mail :
info@oic.co.kr
Tel: 02-703-5000 Fax: 02-714-1109 /
°³ÀÎÁ¤º¸ Ãë±Þ¹æħ